KeyCorp Cuts HCA Healthcare (NYSE:HCA) Price Target to $435.00

HCA Healthcare (NYSE:HCA) had its target price lowered by KeyCorp from $475.00 to $435.00 in a research report sent to investors on Monday morning, MarketBeat.com reports. The brokerage currently has an overweight rating on the stock.

HCA has been the topic of several other research reports. Weiss Ratings downgraded shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Barclays lowered their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research note on Monday. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Deutsche Bank Aktiengesellschaft dropped their price objective on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a report on Tuesday, April 28th. Finally, Argus decreased their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $465.05.

HCA Healthcare Stock Down 2.3%

Shares of HCA stock opened at $408.39 on Monday. HCA Healthcare has a fifty-two week low of $342.71 and a fifty-two week high of $556.52. The firm’s 50 day moving average price is $386.80 and its two-hundred day moving average price is $452.03. The stock has a market cap of $90.60 billion, a price-to-earnings ratio of 13.67, a price-to-earnings-growth ratio of 1.46 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter last year, the firm posted $6.84 EPS. On average, equities analysts forecast that HCA Healthcare will post 29.38 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is 10.45%.

Hedge Funds Weigh In On HCA Healthcare

A number of large investors have recently bought and sold shares of HCA. Palisade Asset Management LLC acquired a new position in HCA Healthcare in the third quarter valued at approximately $26,000. Ares Financial Consulting LLC bought a new stake in shares of HCA Healthcare in the 4th quarter worth approximately $31,000. Cedar Mountain Advisors LLC bought a new position in HCA Healthcare during the 1st quarter worth $33,000. JPL Wealth Management LLC bought a new stake in HCA Healthcare in the third quarter valued at $33,000. Finally, MCF Advisors LLC grew its position in shares of HCA Healthcare by 213.0% during the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after acquiring an additional 49 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s stock outperformed peers during a broadly strong trading session, suggesting some investor support despite recent concerns. HCA stock outperforms competitors
• Positive Sentiment: RBC reiterated its “Outperform” rating, while Mizuho maintained an “Outperform” view and set a $475 price target, implying substantial upside from the recent trading level. RBC reiterates Outperform Mizuho price target
• Positive Sentiment: HCA appointed experienced executives to lead two Tampa hospitals, including a former Oak Hill Hospital executive, and named Jordan Fulkerson chief financial officer of HCA Florida Memorial Hospital. The moves may support local operating continuity. Tampa hospital leadership appointments Memorial Hospital CFO appointment
• Neutral Sentiment: KeyCorp, Truist, and Baird lowered or tempered their HCA price expectations, although the changes reflect analyst caution rather than a broad withdrawal of coverage. KeyCorp set a $435 target, while RBC remained positive. KeyCorp lowers price target Baird forecast Truist price outlook
• Negative Sentiment: A judge rejected a key HCA argument concerning its obligations to provide services at Mission Hospital. Separately, Dogwood Health Trust reported potential noncompliance with the contract governing HCA’s Mission Health acquisition. These developments raise the risk of additional costs, enforcement actions, or operating restrictions. Mission Hospital court ruling Mission contract compliance concerns
• Negative Sentiment: Pomerantz announced an investigation into potential investor claims involving HCA, adding legal overhang and possible reputational risk, although the announcement does not establish wrongdoing. Pomerantz investor investigation

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.